USP21 and esophageal squamous cell carcinoma: Our results demonstrated that DSF treatment impaired USP21-mediated upregulation of G3BP1, activation of Wnt/β-Catenin signaling, and acceleration of ESCC progression, which further supports the crucial role of deubiquitylation activity on USP21-mediated oncogenesis in ECSS.